COVID-19 bivalent boosters protect against Omicron variant

September 14, 2022

Earlier this month, the Food and Drug Administration and Centers for Disease Control authorized bivalent COVID-19 booster doses of the Pfizer and Moderna vaccines. The COVID-19 Vaccine Task Force recommends all eligible persons receive either of these bivalent boosters. Texas Children’s now has appointments available to administer the booster doses. Details are below.

Pfizer
  • Individuals 12 years of age and older
  • At least two months since they have completed primary vaccination or have received the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine
Moderna
  • Individuals 18 years of age and older
  • At least two months since they have completed primary vaccination or have received the most recent booster dose with any authorized or approved monovalent COVID-19 vaccine
Bivalent boosters

The bivalent COVID-19 vaccines, or updated boosters, include an mRNA component of the original strain to provide an immune response that is broadly protective against COVID-19 and an mRNA component in common between the omicron variant BA.4 and BA.5 lineages to provide better protection against COVID-19 caused by the omicron variant.

If you are eligible and would like to receive a booster through Texas Children’s, please click here.

Additional Guidance
  • Texas Children’s strongly encourages, but does not require a bivalent booster vaccine if you have already received a monovalent vaccine booster.
  • For more information on boosters, please refer to this FAQ document on the Texas Children’s website.
Contact

If you have questions related to this new guidance, please contact our Vaccine Employee Support line at 832-VACCINE (832-822-2463).